A phase I open-label, randomised, 3-way crossover drug-interaction study of co-administration of OBE001 and betamethasone in healthy non-pregnant women

Trial Profile

A phase I open-label, randomised, 3-way crossover drug-interaction study of co-administration of OBE001 and betamethasone in healthy non-pregnant women

Completed
Phase of Trial: Phase I

Latest Information Update: 01 Jun 2015

At a glance

  • Drugs Nolasiban (Primary) ; Betamethasone
  • Indications Preterm labour
  • Focus Adverse reactions; Pharmacokinetics
  • Most Recent Events

    • 02 Mar 2015 New trial record
    • 26 Feb 2015 Status changed from active, no longer recruiting to completed according to an ObsEva media release.
    • 26 Feb 2015 Results published in an ObsEva media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top